Skip to main content

What West Pharmaceutical Services's Quarter ended Sep 30, 2026 10-Q says: 4 signals

West Pharmaceutical Services filed its latest 10-Q with the SEC on Oct 29, 2026. It discusses cybersecurity incident, divestiture and margin pressure.

Public (WST)Plastics Manufacturing10,000+ employeeswestpharma.comLinkedIn

Get West Pharmaceutical Services' live signals in Claude or ChatGPT, or by API

AskWhat changed at West Pharmaceutical Services this week? Use Autobound signals for westpharma.com.
Filed
Oct 29, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
23

Source: Autobound Signal API · 51 signals tracked for West Pharmaceutical Services · updated

10-Q · latest 10

What West Pharmaceutical Services's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 4 signals

    SEC EDGAR
  2. 10-Q

    Filed · 9 signals

    SEC EDGAR

Earlier 10-Q filings

Showing 10 of 23 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

West Pharmaceutical Services earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Raised full-year revenue and earnings guidance on strong performance.The company increased its FY25 revenue forecast to $3.06-$3.07 billion and adjusted EPS to $7.06-$7.11, indicating strong business momentum and financial health. This suggests available budget and confidence in future growth.
Annex 1 upgrade initiative accelerating, now expected to drive 200bps of growth.The company is seeing stronger-than-expected demand for upgrades related to new EU regulations (Annex 1), with 375 projects ongoing. This initiative is a key growth driver, creating opportunities for vendors who can support quality and compliance upgrades.
Launching new drug handling business, expecting $20M revenue in 2026.The company is commercializing a new drug handling business in its Dublin facility, with production ramping in early 2026. This expansion into a new service line creates opportunities for vendors supporting new product introductions and manufacturing processes.
Actively hiring and training to expand manufacturing capacity in Germany.The company is investing in its workforce to resolve production constraints at a key HVP manufacturing site. This indicates budget for talent acquisition, training, and operational support to fuel growth.
Capital expenditures decreasing to $275M after a period of elevated spending.While CapEx is down 23% year-to-date compared to last year, the company is still on track to spend a substantial $275 million in 2025. This normalization frees up cash flow but still represents significant investment in facilities and equipment.
New CFO is establishing a new capital allocation policy.The new CFO is actively reviewing and defining a new capital allocation policy to better deploy the company's strong cash flow. This strategic shift could influence future M&A, buybacks, and major internal investment decisions, creating openings for financial and strategic advisory services.

Signal API · MCP

Track West Pharmaceutical Services with the Signal API

One POST /v1/companies/enrich call with westpharma.com returns West Pharmaceutical Services 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"westpharma.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about West Pharmaceutical Services 10-Q

When did West Pharmaceutical Services file its latest 10-Q?
West Pharmaceutical Services filed its latest 10-Q (Quarter ended Sep 30, 2026) on Oct 29, 2026. The one before it was filed on Jul 23, 2026.
What did West Pharmaceutical Services disclose in its latest 10-Q?
From the filing dated Oct 29, 2026: West Pharmaceutical sold SmartDose 3.5mL delivery system and facilities to AbbVie on July 1, 2026
What did West Pharmaceutical Services say on its recent earnings calls?
Q3 FY2025: Raised full-year revenue and earnings guidance on strong performance. (dated Oct 23, 2025).
Where can I read West Pharmaceutical Services's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/105770/000010577026000121/wst-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →